FDA Approves Crizanlizumab, A New Drug For Sickle Cell Disease

Search Featured Websites:

Feature your business, services, products, events & news. Submit Website.

Breaking Top Featured Content:

Novartis will have the go-ahead to begin marketing Adakveo, the first targeted therapy for sickle cell disease.

Press Release Distribution Service

Category: all, Health |
Top Featured Content">Top Featured Content @

Feature your business, services, products, events & news. Submit Website.

TopFeatured.com